ResearcherUniversity of CambridgeActive in the last 2 years

Jason S. Carroll

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3643-0080; OpenAlex author ID A5084427699. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2025: 1 paper

Papers 1

Transcription factor switching drives subtype-specific pancreatic cancer. Last author DOI 10.1038/s41588-025-02389-7 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hideo Baba · 1 shared paper, 2025 · strength 0.17
- Paper Transcription factor switching drives subtype-specific pancreatic cancer. DOI 10.1038/s41588-025-02389-7 ↗
Phyllis F. Cheung · 1 shared paper, 2025 · strength 0.17
- Paper Transcription factor switching drives subtype-specific pancreatic cancer. DOI 10.1038/s41588-025-02389-7 ↗
Barbara T. Grünwald · 1 shared paper, 2025 · strength 0.17
- Paper Transcription factor switching drives subtype-specific pancreatic cancer. DOI 10.1038/s41588-025-02389-7 ↗
Niklas Krebs · 1 shared paper, 2025 · strength 0.17
- Paper Transcription factor switching drives subtype-specific pancreatic cancer. DOI 10.1038/s41588-025-02389-7 ↗
Shalini V. Rao · 1 shared paper, 2025 · strength 0.17
- Paper Transcription factor switching drives subtype-specific pancreatic cancer. DOI 10.1038/s41588-025-02389-7 ↗
Rebecca J. Brais · 1 shared paper, 2025 · strength 0.17
- Paper Transcription factor switching drives subtype-specific pancreatic cancer. DOI 10.1038/s41588-025-02389-7 ↗
Jens Thomas Siveke · 1 shared paper, 2025 · strength 0.17
- Paper Transcription factor switching drives subtype-specific pancreatic cancer. DOI 10.1038/s41588-025-02389-7 ↗
Duncan Ian Jodrell · 1 shared paper, 2025 · strength 0.17
- Paper Transcription factor switching drives subtype-specific pancreatic cancer. DOI 10.1038/s41588-025-02389-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.